Bath PUVA - an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater

被引:1
|
作者
Wainwright, NJ
MacLeod, TM
Ferguson, J
机构
[1] Photobiology Unit, Department of Dermatology, Ninewells Hosp. and Medical School, Dundee
关键词
bath PUVA; trioxsalen (TMP); 8-methoxypsoralen (8-MOP);
D O I
10.1111/j.1600-0781.1997.tb00102.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Trioxsalen (TMP) bath PUVA avoids the side effects of nausea and headache associated with oral 8-methoxypsoralen (8-MOP) treatment and allows shorter irradiation times that can be advantageous in some patients. However we noted that a number of patients developed unusual patterns of phototoxic burning. We thought that this was related to an uneven distribution of the TMP in the bathwater and for this reason, a study of bath water TMP concentrations achieved using different TMP preparations was undertaken. The distribution of 8-MOP in an 8-MOP bath was also measured for comparison. Our results confirm that an uneven distribution of TMP is achieved using TMP capsules or suspension and would explain our observed patterns of burning. With an ethanolic solution of TMP, or the commercial equivalent Tripsor, or with Puvasoralen-8 (an 8-MOP preparation), a homogeneous psoralen distribution is achieved, and they are therefore preferable for use in bath PUVA.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [31] KINETICS OF (C-5)C-14 8-METHOXYPSORALEN (8-MOP) INVIVO
    MALININ, GI
    GLEW, WB
    ROBERTS, WP
    TOWNSEND, L
    NIGRA, TP
    CLINICAL RESEARCH, 1980, 28 (02): : A574 - A574
  • [32] THE OXIDIZED PRODUCTS OF 8-METHOXYPSORALEN (8-MOP) WITH H2O2-NAOCL
    MURAKAMI, N
    MORIMOTO, T
    MATSUO, K
    NAGAI, SI
    UEDA, T
    SAKAKIBARA, J
    MIZUNO, N
    ESAKI, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (10) : 2715 - 2717
  • [33] BIOACTIVITY OF A NEW LIQUID FORMULATION OF 8-METHOXYPSORALEN (8-MOP) - TIME COURSE AND EFFECT OF DIET
    LEVINS, PC
    GANGE, RW
    MOMTAZ, TK
    PATHAK, MA
    PARRISH, JA
    CLINICAL RESEARCH, 1983, 31 (02): : A582 - A582
  • [34] PERSISTENT PHOTOSENSITIVITY INDUCED BY TOPICAL AND ORAL 8-METHOXYPSORALEN (8-MOP) AND SUBERYTHEMOGENIC UVA IRRADIATION
    GANGE, RW
    LEVINS, PC
    MURRAY, J
    ANDERSON, RR
    PARRISH, JA
    CLINICAL RESEARCH, 1983, 31 (02): : A567 - A567
  • [35] PHOTOACTIVELY AVAILABLE FRACTION OF TOTAL 8-METHOXYPSORALEN (8-MOP) IN TISSUES AND BODY-FLUIDS
    GLEW, WB
    MALININ, GI
    ROBERTS, WP
    MCKEEVER, G
    NIGRA, TP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1979, 72 (05) : 277 - 278
  • [36] BIOACTIVITY OF A NEW LIQUID FORMULATION OF 8-METHOXYPSORALEN (8-MOP) - TIME COURSE AND EFFECT OF DIET
    LEVINS, PC
    GANGE, RW
    MOMTAZ, K
    PATHAK, MA
    PARRISH, JA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 80 (04) : 305 - 306
  • [37] EFFECTS OF 8-METHOXYPSORALEN (8-MOP) AND ULTRAVIOLET A (UVA) ON HELPER T-CELL ACTIVITY
    BERGER, C
    EDELSON, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1979, 72 (04) : 198 - 199
  • [38] PERSISTENT PHOTOSENSITIVITY INDUCED BY TOPICAL AND ORAL 8-METHOXYPSORALEN (8-MOP) AND SUBERYTHEMOGENIC UVA IRRADIATION
    GANGE, RW
    LEVINS, PC
    MURRAY, J
    ANDERSON, RR
    PARRISH, JA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 80 (04) : 306 - 306
  • [39] PUVA bath photochemotherapy of lichen sclerosus et atrophicus with 8-methoxypsoralen
    vonKobyletzki, G
    Freitag, M
    Hoffmann, K
    Altmeyer, P
    Kerscher, M
    HAUTARZT, 1997, 48 (07): : 488 - &
  • [40] Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides
    Weber, F
    Schmuth, M
    Sepp, N
    Fritsch, P
    ACTA DERMATO-VENEREOLOGICA, 2005, 85 (04) : 329 - 332